The Chamber of the Bolivian Pharmaceutical Industry (Cifabol) made it clear that the drug “Ibuflamar-P Ibuprofen with Paracetamol” withdrawn from the Argentine market is not manufactured by any company or national laboratory.
Yesterday, the Argentine newspaper Página 12 published a notice that the “Drugs, Food and Medical Technology Authority (Anmat) has banned and withdrawn from circulation the drug ‘Ibuflamar-p ibuprofen with paracetamol’, manufactured by Indoco Remedies Ltd., Bolivia “. as the drug is not registered in the country, so it poses a potential risk to people.
This news was replicated in Los Tiempos and other national media.
However, in contact with Los Tiempos, Cifabol reported that “we as the national pharmaceutical industry would like to make it clear that the drug Ibuflamar-P is not manufactured by any Bolivian company or laboratory.”
“This drug is of Indian origin and is marketed by an importer,” said Alberto Torrez, manager of the Chamber of the Bolivian Pharmaceutical Industry (Cifabol).